The new distribution service uses Invatech's Patient Medication Record (PMR) system, called Titan, which was accredited by the NHS a little over a year ago. Titan has now been developed further to support the company's Home Pharmacy service, and integrate with MWI.
The company says the new system offers practices a seamless workflow between prescribing, dispensing and logistics systems.
Tariq Muhammad, CEO of Invatech Health, said: "“The use of PMR systems for the veterinary market has been very light touch until now. Knowing that that we can bring the same level of efficiency and workflow to a new market presents an opportunity to support animal health in the same way that we do for human health."
Alan White, Commercial Director at MWI Animal Health, said: “The Covid pandemic has presented many challenges to veterinary professionals in the UK. Travel restrictions and social distancing measures make it difficult for animal owners to collect the medications and treatments they need from veterinary practices.”
“We are excited to be able to work with Invatech to provide an innovative solution to this problem, where vets can send the medications needed directly to their client. Working in partnership with veterinary practices and Invatech means we can move animal health forward together.”
For more information, visit: https://www.invatechhealth.com/
Vetbromide is presented as a 600mg double divisible tablet for both large and small dogs, and for greater flexibility with dose titration. Tablets are blister packed for ease of storage and dispensing, with a four-year unopened shelf life.
Alongside the launch, TVM has prepared a range of product support materials, including: product guidelines, treatment and monitoring guidelines, seizure management ‘lunch and learn’ sessions, and pet owner information.
TVM has also created a free e-learning tool which takes veterinary staff through the process of diagnosing, treating and monitoring dogs with suspected epilepsy.
Will Peel, product manager at TVM said: "The addition of Vetbromide to our epilepsy range allows vets more flexibility when treating epileptic patients. To further assist vets, we are also offering a wide range of free literature and in-practice support to ensure that veterinary staff are up to speed on such a common, yet at times complicated, topic.’
For more information, visit www.tvm-uk.com/epilepsy, or contact your TVM UK Territory Manager.
The webinar, titled: ‘When the coughing won’t stop…. what to do when standard BRD treatment protocols aren’t getting to the bottom of it’, aims help vets manage complex outbreaks that happen despite best practice management and treatment protocols.
The full programme includes:
The event is being held live so you can submit questions to the speakers, but the session will be recorded, so it can be watched again later.
Attendees will receive a certificate for one hour of CPD and the link to the recorded webinar.
To register, email the event team by 27 November 2020 at brdwebinar-group@ceva.com. In the email, please give your name and the email address to which you would like the registration link sent.
Mandisa qualified from the Royal (Dick) Vet School in Edinburgh in 2008 and has since spent much of her career working in emergency and critical care.
She served as the first black president of the RCVS in 2020/21 and has also worked for Harper Adams University as a lecturer in veterinary sciences.
Mandisa will replace Laura Playforth, who is joining IVC Evidensia as group QI director, on the Vets Now board.
She said: “I’m delighted to be joining the Vets Now family at such an interesting and challenging time for the veterinary professions.
“I look forward to working together through innovative approaches to ensure our teams continue to deliver the highest standards of clinical care and client services.”
The first is the introduction of Specialist training and status for general practitioners in primary care, for which the RCVS project will now develop a new five-year curriculum and an implementation plan.
The RCVS will also be looking closer at the definition of veterinary clinical roles and developing guidance for the profession and wider public on the different clinical career statuses available to veterinary surgeons.
Thirdly, the College will identify different ways in which vets can access the teaching and learning opportunities, clinical experience/cases, supervision and support that is required for them to complete specialist training and obtain RCVS Specialist status.
This will include looking at how access to specialist training can be widened beyond the typical internship/residency model, to include training models more accessible from primary care practice, and for those at different career and life stages.
Kate Richards MRCVS, Chair of the RCVS Education Committee, said: “These exciting and progressive proposals are visionary as far as the career and development structure of the veterinary clinical profession is concerned.
“It means there will be new prospects for those in general practice and those who want to achieve Specialist status by different means, as well as a more defined career structure for the profession that will be clearer to the profession and general public alike.
"With around 75-80% of veterinary professionals working in clinical practice this project will deliver a substantial positive impact.
“These are the early pages of a very exciting new chapter for veterinary clinical careers, and we will be asking for your help to write it, as we will be holding a number of consultations in the coming years, including on the programme for Specialist in Primary Care and the definition of clinical roles.
RCVS President Dr Sue Paterson FRCVS added: “There are two aspects of the project that I particularly welcome.
"First is the impact this could have on both recruitment and retention as vets are offered additional, and more diversified, career options and expanded roles in a variety of clinical settings.
"Second, as a specialist dermatologist myself, I really value the fact that we will be looking at ways to widen participation and increase accessibility to specialist training from primary care practice, as the residency/internship route is very intensive and not necessarily suitable for everyone.
A similar process to develop and enhance clinical career pathways for veterinary nurses is now also being considered, this would include the development of an ‘Advanced Veterinary Nurse’ status and clearer information on the veterinary nursing role and what it entails.
The Livestock Adviser of the Year Award recognises those who have made a real difference to the operations of livestock farmers.
Julian focuses on dairy cow health and his particular interests include nutrition and benchmarking herd performance. Amongst other things, he has helped one large Dorset dairy farm reduce its antibiotic usage by two thirds over an eight year period.
Julian said: "I was honoured to be named Livestock Adviser of the Year. This work is my passion – I love working together with farmers, getting involved in all aspects of herd management and thinking through different options to improve herd health and productivity."
Runners up for the award were Phil Baynes, Managing Director of Baynes Nutrition, and Ed Hill, veterinary surgeon at Thrums Veterinary Group.
Friars Moor, Baynes Nutrition and Thrums Veterinary Group are all members of the XLVets community of independent veterinary practices.
Alice Renner, Farm Marketing Executive of XLVets, said: "We were so pleased to hear of these awards going to such hard-working and deserving people. And it’s a great accolade for our members – reflecting how XLVets practices strive for clinical excellence and really get invested in the success of their clients."
The RSPCA reports that it has saved nearly 400 animals from flooding, including 40 fish, in the last 3 days alone.
The koi carp were rescued from a pond in Wraysbury, Berkshire, which was being overcome by rising floodwater.
Other rescues have included:
The charity says its flood rescue team has helped 586 animals affected by floods since Jan, with 386 of those in the last three days alone. Their efforts were praised by Labour leader Ed Milliband yesterday, who was at the scene with an RSPCA water rescue team in Wraysbury.
RSPCA flood rescue co-ordinator Jason Finch said: "The water rescue teams on the ground are doing an amazing job with limited resources. We will continue to do everything we can to help animals, and humans, during this difficult time and are so grateful for all the support our workers have received from the public."
Photograph courtesy RSPCA
Petplan has announced that it has won a formal tender to become the chosen pet insurance provider for Vets4Pets and Companion Care, as part of a five year deal to provide cover for over 250 practices.
Simon Masding, Petplan's Head of Sales and Partnerships said: "As the leader in the pet insurance market for over 36 years, we have a rich history of working with veterinary practices across the UK and it is fantastic to see our unrivalled support recognised as part of a formal tender process. This partnership demonstrates our passion for working with and supporting the veterinary profession.
"We are delighted to be Vets4Pets and Companion Care's chosen pet insurance provider and look forward to working together to help give even more pets access to quality insurance cover and an excellent claims experience."
Companion Care Commercial Director Andrei Balta said: "Like Petplan, we put pet welfare and owner's peace of mind first. Through the development of the tender process, it was clear that Petplan offers not only a world class service for pet owners, but our businesses share similar values and a deep respect for the industry."
The interactive checklist is designed to help practitioner and farmer to work closely together to draw up a workable action plan to improve youngstock health.
MSD Animal Health ruminant veterinary adviser Kat Baxter said: "This new checklist-based tool explores, records and scores calf health performance across five core areas to identify the strengths and weaknesses of any rearing unit’s environment and processes.
"Working through a series of 10 questions within each core area – designed to tease out where a rearing unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention. What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to monitor progress against agreed targets. Vets can also use the scores to benchmark their clients’ farms against each other."
Vets interested in using the new checklist-based tool on farm should contact their local MSD Animal Health account manager for further information.
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
Dechra says necrotic enteritis can be treated with a variety of therapeutic antibiotics but that the first choice antibiotics¹ for treatment are narrow spectrum antibiotics, like phenoxymethylpenicillin.
Phenocillin is an 800 mg/g powder for use in drinking water. It is lactose free, and Dechra says its high solubility makes it ideal for concentrated stock solutions and convenient for modern poultry farming. There is a zero withdrawal time so egg production is unaffected.
Dechra Brand Manager Emma Jennings said: “Necrotic enteritis is the most common bacterial disease in modern broiler flocks that can be financially devastating for farmers.
"The high concentration means easy dosage and handling with less waste and the lactose free formula reduces the risk of biofilm development resulting in a high quality and effective product, supporting the responsible use of antimicrobials.
"Phenocillin is a highly effective treatment and we anticipate it will become the preferred solution for veterinary professionals and end users to treat this disease that can very suddenly devastate broiler flocks."
For more information, visit: http://bit.ly/2nAboGU
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
The company will continue to offer attended modular training options as well as small group practical teaching sessions at its wet labs in Swindon and Sheffield. It says these events will complement its online programmes and will provide stand-alone training for vets wishing to learn new surgical and diagnostic skills.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes, together with exams that can be taken remotely.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
“We start this new chapter in a world changed irrevocably by COVID-19. It is a world in which veterinary professionals are demanding more flexible ways of learning and showing a hunger to achieve additional qualifications. With this in mind, we will be working to offer a combination of high quality practical, remote and blended learning that will make the achievement of a postgraduate qualification a realistic ambition for every vet."
Animalcare says hydrocortisone aceponate is a potent, topical anti-inflammatory, proven to quickly relieve itchy and inflamed skin in dogs.
The new product is applied as a spray, designed to make it easy to target affected areas of skin.
Hydrocortisone Cutaneous Spray Solution is presented in a 76 ml size with a two-year shelf life, six months once opened.
Animalcare Product Manager Eleanor Workman Wright said: “Skin problems are extremely common in dogs.
"They can often cause great discomfort to dogs and concern to their owners.
"We believe that Hydrocortisone Cutaneous Spray Solution will be a useful addition to the range of treatment options currently available to vets as they consider the most appropriate care plan for their patients.”
Vet Direct says the unit, which is used for the diagnosis and monitoring of anaemia in dogs, cats and horses, requires only a simple ear-prick test to deliver a result.
Leon Wright, managing director at Vet Direct, said: "The AniPoc device eliminates the need to draw blood with a syringe, a simple pin prick is enough, and is perfect for both veterinary practices and home visits.
"The speed and accuracy of the product means that it is better equipped to monitor animals undergoing anaesthesia or transfusions, and can be used to effectively screen animals taking part in Pet Blood Banks and mobile clinics."
Vet Direct says the AniPoc also delivers results much faster than a centrifuge and doesn’t require any time to be spent in the lab; a process which can take 10-20 minutes to get a result - by which time they are often out-of-date in critical cases.
The AniPoc Handheld Monitor and Starter Kit is available from Vet Direct for £250.
For more information, visit www.vet-direct.com or call 0800 068 3300.
The toolkit contains everything a practice needs to create its own lumps and bumps awareness campaign including social media posts, videos, newsletter content and client literature.
Up to 1 in 4 pets will develop cancer over their lifetimes1 and mast cell tumours account for 1 in 5 cutaneous neoplasms2, so early diagnosis of skin lumps and bumps is of course critical.
Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Making the most of cuddle time with our pets, feeling for lumps and bumps, can make a huge difference to the early detection of skin abnormalities.
"Thanks to innovative new products like Stelfonta, the options available to veterinary surgeons to treat skin tumours in dogs has never been greater, so it’s an ideal time to educate pet owners on the importance of an early diagnosis".
The toolkit is available on the Virbac Resource Library which can be found by creating an account at https://vet-uk.virbac.com/home.html or from your Virbac Territory Manager.
References
The self-adhesive dressing, which uses a patented natural polymer, adapts to any part of the body and sets fast, acting as a waterproof barrier to the external environment which shields the site from unwanted moisture and bacterial ingress and allows the tissue underneath to repair in a protected environment.
It is proven to prevent the loss of therapeutic sprays when it is used as a barrier1.
The company says NoBACZ Bovine is easy to apply with a clean gloved hand and offers up to seven days’ protection without the need to reapply.
It is suitable for use on any site of the body, except the eyes, and has been especially widely used on hooves, horn buds and udders.
The liquid barrier dressing does not need to be removed as it will self-degrade and its ingredients dissolve naturally with no residue.
Dr Jonathan Powell, Director of Biomineral Research and Imaging at the University of Cambridge’s Department of Veterinary Medicine, and chief executive officer and co-founder of NoBACZ Healthcare, said: “Following several years of research at the University of Cambridge and comprehensive market analysis which identified an unmet need across the farming industry, we are absolutely delighted to launch NoBACZ Bovine, which offers unparalleled protection against harsh farm conditions, revolutionising wound protection in cattle and enhancing the health and welfare of the national herd.”
Mike Kerby, veterinary surgeon from Synergy Farm Health, who has used NoBACZ Bovine over many months, added: “I have been using NoBACZ Bovine for a while in cattle affected with UCD (udder cleft dermatitis) and DD (digital dermatitis) lesions as well as on wounds and granulomas.
"It is my clinical impression that it counters bacterial colonisation rapidly and promotes re-epithelialisation, which in turn helps to prevent the occurrence of proud flesh or reduces the mass of any existing granulomata.
"Application is simple and quick, with clients also finding it easy to reapply regularly within set treatment protocols.
"In addition to this, it was seen as a huge advantage that bandages and their removal are not involved, nor are antibiotics, making it labour saving, sustainable and eco-friendly.”
www.nobacz.com
Reference
Supreme Petfoods has launched the VetCarePlus range of Monoforage® diets for rabbits.
According to the company, the new range represents an entirely new generation of rabbit food, made possible because of a breakthrough in production technology.
The big advance is the level of fibre within a mono-component style diet: 28%-34% across the range, along with the inclusion - uniquely - of essential long fibre particles. Supreme says the result is a less dense food that is beneficial for a rabbit's sensitive digestion system, with the added benefit of extending the feeding time, which is good for dental wear.
The company also says VetCarePlus performs exceptionally well in palatability tests and that it's been widely welcomed throughout the rabbit welfare community. Molly Varga BVetMed DZooMed MRCVS said: "This is exactly what convalescing rabbits need, an excellent level of fibre with no chance of selective feeding plus a good slow chew rate".
The range comprises three specific formulas for Weight Management, Urinary Tract Health and Digestive Health.
Supreme says feedback on samples sent to welfare organisations, veterinary schools and practicing vets so far has been very positive. Vets are delighted with the simplicity of the products, and have welcomed the way Monoforage encapsulates all the benefits of hay, with minimal processing compared to other diets.
Molly Varga added: "All the benefits of hay are preserved while this diet gives more volume of fibre per measurement of food than I have seen before, without increasing the weight (and therefore energy) components". VetCarePlus delivers the maximum possible crude fibre and long fibre content available to date.
Claire Hamblion, Marketing Manager for VetCarePlus said: "Supreme Petfoods feels that VetCarePlus is pushing forward the boundaries on specialist diets for rabbits. Monoforage provides completely unique levels of fibre and we're delighted that all the feedback we have received from a wide range of experts has been exceptionally enthusiastic and welcoming".
For more information on how to stock VetCarePlus products contact Supreme Petfoods at sales@supremepetfoods.com or visit http://www.supremeprofessional.com/
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
The College has confirmed that it has now received an official complaint about the matter and it is now investigating under its normal 'concerns' investigation process.
Professor Argyle made a private statement about the allegations to RCVS Council at its meeting today, having already answered written questions from a number of Council members in the preceding days.
The Council did not ask Professor Argyle to step aside, but acknowledged that this was his choice, made for personal reasons.
The College said that in line with its normal protocols, and to ensure fairness for all parties, it will not make any further public comment about the investigation for the time being. However, it wanted to stress that it remains firmly committed to following due and proper process in all its regulatory activities.
Camilla, who was shortlisted as a finalist for Innovator of the Year at the 2025 Digital Women Awards, says her mission has always been to give first-opinion vets the tools and confidence to get the most from ultrasound in everyday practice – and the new tool is a big step forward in that vision.
The tool:
Camilla says the final report is fully editable, but much of the “heavy lifting” is done — saving time, reducing second-guessing, and producing reports that are more useful for colleagues, clients, and patient care.
https://www.fovu.co.uk/
https://www.fovu.co.uk/fovu-report-video
Bayer Animal Health has obtained two new licensed indications for its antiparasiticide, Advocate.
The first is that the product is now licensed for the treatment of Crenosoma vulpis using a single dose. The second is that in addition to the existing treatment of Angiostrongylus vasorum claim, Advocate is now indicated for its prevention, using monthly spot-on applications.
This comes at a time when, according to Bayer, independent market research shows that vets are diagnosing Angiostrongylus vasorum at an increasing rate. Figures for 2010 place the incidence of vets who have confirmed cases at 37%, more than double the 16% confirmed in 2008, with a further 19% of vets reporting suspected cases.
Bayer is also stepping up its 'Be Lungworm Aware' consumer campaign, with the addition of a local and national radio campaign throughout October. The public information style advert will warn owners of the dangers associated with the parasite A.vasorum, and urging them to stay vigilant for signs their dog may be infected.
Veterinary staff can also direct clients who wish to learn more about lungworm to http://www.lungworm.co.uk/.
For more information on Advocate, please contact your sales representative or telephone Bayer on 01635 563000.
CEVA Animal Health has launched Diarsanyl Plus, a new intestinal support paste for dogs, cats and small animals containing prebiotics.
Diarsanyl Plus contains the same unique combination of ingredients as Diarsanyl - montmorillonite, Na+, Mg2+ and K+ ions and dextrose - but now also contains prebiotics called fructo-oligosaccharides (FOS).
According to the company, montmorillonite maintains intestinal function by coating and protecting the enterocytes and absorbing toxins, Na+, Mg2+ and K+ ions help maintain electrolyte levels and dextrose provides a much needed energy source for the small intestine. The prebiotics help maintain normal intestinal flora by promoting the growth of good bacteria such as bifidobacteria and lactobacilli and stimulating the production of short chain fatty acids (SCFAs) - acetate, propionate and butyrate - which are important energy sources for the large intestine.
Fraser Broadfoot, product manager at CEVA Animal Health said: "Diarsanyl Plus will build on the proven efficacy of Diarsanyl by including prebiotics that naturally balance the intestinal flora of animals with digestive upsets and diarrhoea. The new easy-to-use syringes and palatable formulation will also make it easier for pet owners to administer."
Diarsanyl Plus is available in 10ml, 24ml and 60ml pack sizes for a variety of species, from small animals to large dogs.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
CVS has announced its acquisition of the West End Veterinary Partnership, an Edinburgh-based veterinary practice, bringing the number of practice groups owned by the company to 100, operating out of 267 sites across the UK.
West End Vets employs around 12 staff. Its main site is in Bread Street and it has two branches elsewhere in the city. Owners David Rimer and Maurice Hunter are joining CVS as joint Clinical Directors.
Simon Innes, CVS Chief Executive, said: "We are rapidly broadening the range of practices within CVS, both in terms of the type of practice and in terms of geographic spread. West End Vets is a successful and popular practice in Edinburgh and we are delighted that it has now joined our family."
Founded in 1999 and run principally by vets, CVS employs more than 3,000 staff at its practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, three pet crematoriums and five veterinary laboratories.
The case against Jose Ignacio Messa MRCVS related to two heads of charge against him.
The first charge was that, on 13th September 2015, Mr Messa failed to provide adequate and appropriate care to Barney, a border collie. The second charge was that on 14th September 2015 Mr Messa failed to ensure adequate and appropriate on-going care for Barney after his examination of him, including failing to take sufficient steps to ensure that Barney was referred urgently to the care of a referral practice and failing to ensure there were adequate arrangements in place for his ongoing care.
Barney was presented to the Basingstoke practice where Mr Messa was employed having suffered a severe 'stick injury' to his jaw on 12th September.
The Committee heard that, on 13th September, Mr Messa re-examined Barney, administered medication and then discharged him to be cared for at home by his owners. During the examination the owners alerted Mr Messa to the condition of the skin on Barney’s neck, but the Committee heard Mr Messa had felt the area and reassured them it was not something to be concerned about.
The Committee heard that at some point on 13th September, after he was discharged, Barney developed a foetid smell from his mouth caused by an infection and the next day his owners went back to the practice because Barney’s condition had deteriorated – he was unable to walk and had laboured breathing.
On 14th September Mr Messa admitted and sedated Barney and examined him again, noting a hole in the side of his throat that was infected. He recommended referring Barney to a referral practice for further treatment, which was agreed by his owners.
The Committee heard that the referral practice was contacted by a veterinary nurse at the practice and that an appointment for 9am on 15th September 2015 was booked directly with the owner. It also heard that, during his time at Mr Messa’s practice, Barney did not receive intravenous fluids or any further antibiotics.
Barney’s owners said they met with Mr Messa again at around 5pm on 14th September when they came to collect Barney, this was disputed by Mr Messa, and the Committee were not satisfied so as to be sure that it had been Mr Messa who had met the owners and discharged Barney although the Committee found that all the witnesses had been honest and reliable.
Barney was admitted to the referral practice on 15th September but, as a result of sepsis, he suffered a cardiac arrest and died at 10.30pm.
In respect of the first charge the Committee concluded that, on 13th September, Mr Messa made only a rudimentary examination of Barney, and the absence of such basic clinical examination of the temperature, the respiration rate and the pulse of Barney was a failure on the part of Mr Messa and that, furthermore, he did not choose the best course of antibiotic treatment for the wound and infection.
In respect of the second charge Mr Messa admitted that he did not provide fluid therapy to Barney on 14th September before he was discharged.
With reference to the remaining aspects of the charge the Committee took into account the Code of Professional Conduct, particularly in respect of the need for veterinary surgeons to refer cases responsibly and the Code’s supporting guidance on referrals.
The Committee determined that, having delegated the arrangements of the referral to a veterinary nurse, Mr Messa made no attempts to follow up and ensure it was a same-day appointment when this would have better suited the severity of Barney’s condition. The Committee found that he was unaware of Barney’s location or of the time of the appointment and did not make provision for antibiotic or fluid therapy.
Having found the majority of the charges against Mr Messa proven, the Committee then considered whether this amounted to serious professional misconduct.
Disciplinary Committee member Stuart Drummond, who was chairing the Committee and speaking on its behalf, said: "In the light of the facts found proved and considering that disgraceful conduct in a professional respect is that which is conduct falling far below that expected of a veterinary surgeon, the Committee had concluded that the heads of charge, when taken individually, or collectively, do fall below the standard expected.
"However, as a matter of judgement, the Committee did not conclude that Mr Messa’s conduct fell far below the requisite standard and therefore did not amount of disgraceful conduct in a professional respect.
"Whilst the Committee did not find Mr Messa’s actions fell far below the requisite standard, there were concerns expressed about several aspects of this case. There were a number of missed opportunities which occurred; in particular the Committee notes the failure of the care plan and to take adequate steps to ensure that the referral process has been timeously effected."
At the heart of the campaign is a website - www.beatdogheartdisease.co.uk - where dog owners can learn more about mitral valve disease and dilated cardiomyopathy, find out which breeds are most at risk and read more about the diagnosis and management of canine heart disease.
Boehringer has also created a Facebook page - www.facebook.com/beatcanineheartdisease - offering regular updates on heart health and a platform for owners to share their stories. Owners can also use the ‘Love Your Dog’s Heart’ Facebook profile frame to help spread awareness of the disease.
The aim of the campaign is to get pet owners thinking about mitral valve disease and having it treated whilst it is still in the asymptomatic phase, in order to slow the disease progression and delay the onset of heart failure1.
Vetmedin practices can access additional ‘Love Your Dog’s Heart’ campaign materials via the Boehringer Ingelheim Resource Hub at boehringer-ingelheim-resourcehub.co.uk.